BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 28 filers reported holding BICYCLE THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,553,096 | -18.2% | 575,067 | +3.9% | 0.04% | -12.8% |
| Q2 2023 | $14,128,689 | +44.4% | 553,632 | +20.3% | 0.05% | +38.2% |
| Q1 2023 | $9,786,859 | -13.1% | 460,125 | +20.9% | 0.03% | -17.1% |
| Q4 2022 | $11,264,428 | -41.0% | 380,555 | -53.7% | 0.04% | +7.9% |
| Q3 2022 | $19,102,486 | +22.9% | 821,280 | -11.3% | 0.04% | +31.0% |
| Q2 2022 | $15,539,593 | +21.9% | 926,054 | +218.8% | 0.03% | +61.1% |
| Q1 2022 | $12,747,746 | +44.2% | 290,508 | +100.0% | 0.02% | -21.7% |
| Q4 2021 | $8,841,000 | +7.0% | 145,252 | -26.9% | 0.02% | 0.0% |
| Q3 2021 | $8,263,000 | -31.1% | 198,673 | -49.7% | 0.02% | +35.3% |
| Q2 2021 | $11,992,000 | +103.0% | 395,020 | +99.7% | 0.02% | -5.6% |
| Q1 2021 | $5,908,000 | +127.0% | 197,799 | +36.4% | 0.02% | +125.0% |
| Q4 2020 | $2,603,000 | – | 144,997 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,915,274 | $57,209,000 | 21.43% |
| Atlas Venture Advisors, Inc. | 612,696 | $18,301,000 | 3.38% |
| Logos Global Management LP | 800,000 | $23,896,000 | 2.33% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,957,961 | $58,484,000 | 1.28% |
| Ghost Tree Capital, LLC | 150,000 | $4,481,000 | 1.05% |
| Parkman Healthcare Partners LLC | 75,454 | $2,254,000 | 0.52% |
| MOODY ALDRICH PARTNERS LLC | 74,060 | $2,212,000 | 0.32% |
| Point72 Asset Management, L.P. | 1,577,493 | $47,120,000 | 0.22% |
| Eventide Asset Management | 411,838 | $12,302,000 | 0.18% |
| SAMLYN CAPITAL, LLC | 437,728 | $13,076,000 | 0.18% |